刻意选择小尺寸覆膜支架行胸主动脉腔内修复术治疗Stanford B型主动脉夹层的疗效
本研究回顾性分析2015至2022年间82例接受胸主动脉腔内修复术(TEVAR)治疗的急性或亚急性Stanford B型主动脉夹层患者,采用刻意选择小尺寸覆膜支架的策略(支架与自体近端锚定区直径 Oversize 率为0.3%±4.7%)。结果显示院内死亡1例,逆行A型夹层1例,无远端支架诱导的新发破口,1a型内漏22例(26.8%),其中12例在1年内自发消失;主动脉弓水平和第8胸椎水平的完全主动脉重塑率分别为86.8%和75.0%,1年及3年生存率分别为97.5%和93.6%,免于再干预率均为84.7%。作者认为该策略安全且可获得可接受的主动脉重塑,尽管1a型内漏发生率较高,但多数在中期随访中减轻。
要点
- 刻意小尺寸TEVAR治疗急性或亚急性Stanford B型主动脉夹层,支架Oversize率为0.3%±4.7%。
- 1a型内漏发生率为26.8%(22/82),其中12例在1年内自发消失。
- 主动脉弓水平和第8胸椎水平完全重塑率分别为86.8%和75.0%,3年生存率93.6%。
核心结论
- 刻意小尺寸TEVAR是安全的,尽管1a型内漏发生率较高,但仍获得了可接受的主动脉重塑。
- 1a型内漏是可接受的,因其主要在中期随访期间减轻。
研究设计与样本
- 回顾性病历审查研究,纳入2015年至2022年间因急性或亚急性Stanford B型主动脉夹层接受TEVAR的82例患者。
- 在锁骨下动脉远端测量真腔直径,并选择相同直径的覆膜支架;若假腔压力移位导致变形明显,则测量锁骨下动脉近端部位的直径。
- 分析患者特征、手术、院内和随访数据以及主动脉重塑;主动脉直径采用单因素方差分析及Dunnett检验,生存率和免于再干预率采用Kaplan-Meier曲线估计。
主要发现
- 随访率为98.4%;平均年龄58.3±12.3岁,男性76例(92.7%)。
- 覆膜支架平均直径30.9±3.2 mm,自体近端锚定区平均直径30.8±3.0 mm,支架相对自体近端主动脉直径的Oversize率为0.3%±4.7%。
- 院内死亡1例,逆行A型主动脉夹层1例,远端支架诱导的新发破口0例,1a型内漏22例(26.8%);其中12例1a型内漏在随访1年内自发消失。
- 主动脉弓水平完全主动脉重塑59例(86.8%),第8胸椎水平完全重塑51例(75.0%);主动脉弓和降主动脉直径较术后测量值显著减小(P<.001)。
- 1年和3年生存率分别为97.5%和93.6%;1年和3年免于再干预率均为84.7%。
关键数值与推荐
- 支架相对自体近端主动脉直径的Oversize率为0.3%±4.7%。
- 1a型内漏发生率为26.8%(22/82),其中12例在1年内自发消失。
- 主动脉弓水平完全重塑率为86.8%(59例),第8胸椎水平为75.0%(51例)。
- 1年和3年生存率分别为97.5%和93.6%,免于再干预率均为84.7%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Thoracic endovascular aneurysm repair (TEVAR) is widely used for the treatment of aortic dissection. Endograft oversizing is a risk factor for stent graft-induced new entry tears and retrograde type A aortic dissection. However, there is no clear consensus on the optimal graft size selection for Stanford type B acute or subacute aortic dissection (TBAD). Herein, we examined the safety and efficacy of TEVAR using an intentionally undersized endograft to treat TBAD. METHODS: This retrospective chart review study included 82 patients who underwent TEVAR for acute or subacute Stanford TBAD between 2015 and 2022. We measured the true lumen diameter just distal to the subclavian artery and opted for a stent graft of the same diameter. In instances where deformation resulting from false lumen pressure displacement was pronounced, we measured the diameter at the site just proximal to the subclavian artery. Patients' characteristics, procedural, in-hospital, and follow-up data, and aortic remodeling were analyzed. The aortic diameter was analyzed using one-way analysis of variance followed by Dunnett's test. Survival and freedom from reintervention were estimated using Kaplan-Meier curves. RESULTS: The follow-up rate was 98.4%. The mean age was 58.3 ± 12.3 years, and 76 were men (92.7%). The mean diameters of the stent graft and native proximal landing zone were 30.9 ± 3.2 mm and 30.8 ± 3.0 mm, respectively. The oversize rate of the stent graft in relation to the native proximal aortic diameter was 0.3% ± 4.7%. In-hospital mortality was observed in one patient, retrograde type A aortic dissection in one patient, distal stent graft-induced new entry tear in zero patients, and type 1a endoleak in 22 patients (26.8%). Type 1a endoleaks, characterized by antegrade false lumen blood flow originating from the primary entry, in 12 patients spontaneously disappeared within 1 year of follow-up. According to aortic remodeling, 59 patients (86.8%) achieved complete aortic remodeling at the aortic arch level and 51 (75.0%) at the eighth thoracic vertebral level. The diameters of the aortic arch and descending aorta were significantly reduced compared with the postoperative measurements (P <.001). Survival rates were 97.5% and 93.6% at 1 and 3 years, respectively. Freedom from reintervention was 84.7% and 84.7% at 1 and 3 years, respectively. CONCLUSIONS: Intentionally undersized TEVAR was safe and achieved acceptable aortic remodeling despite a high rate of type 1a endoleaks. A type 1a endoleak was acceptable as it primarily diminished during the mid-term follow-up.
引用
- Naganuma M, Hayatsu Y, Tsuruhara R, et al. Efficacy of intentional undersized thoracic endovascular repair for Stanford type B aortic dissection. J Vasc Surg. 2024. PMID: 38642671. doi:10.1016/j.jvs.2024.04.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。